Johnson & Johnson (JNJ) valuation

Share price $227.50 · Close 2026-04-24

Price-to-Earnings

P/E · Trailing Diluted
26.33×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
28.06×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
3.56%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
20.67×
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
5.77×
P/S history →

Price-to-Book

P/B · Latest filing
6.85×
P/B history →

Expectations investing: what does the price imply?

Scenario margin +12pp above start

Rappaport-style reverse-DCF. We start from the current market price ($227.50 × 2.45B shares = $556.28B market cap, $589.58B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 20.7%
    Source is analyst consensus (absolute forecast, TTM-anchored) of 4.7%; the scenario bumped Y1 by +16.0pp to reconcile.
  • Target EBIT margin (Y10): 37.7%
    Scenario lands above the 3-yr max of 34.6% (starting 25.9%, ending 37.7%).
  • High-growth plateau: 3 years
    Tier default for Y2 at 6.3%.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
-4%
Y4–10
+4%
Terminal
+100%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.

Facts · TTM as of 2026-03-29 (Q12026)

Share price
$227.50
Diluted shares
2.45B
Total debt
$54.99B
Cash & equivalents
$21.69B
Revenue
$96.36B
Pretax income (cont. ops)
$24.94B
Filer does not tag us-gaap:OperatingIncomeLoss; using pretax income from continuing operations as the operating-income base. For banks this is effectively operating income (interest expense is a core cost); for oil majors and some pharma filers it's a close proxy with small non-operating items mixed in.
Pretax margin
25.9%
Operating cash flow
$22.87B
CapEx
$5.09B
Observed YoY growth
7.9%
Analyst current-FY growth
7.1%
Analyst next-FY growth
6.3%
3-year revenue CAGR
6.4%

Assumptions

Initial revenue growth
4.7%
from analyst consensus (absolute forecast, TTM-anchored)
(analyst FY-over-FY consensus: 7.1% — shown effective rate normalises it against our TTM base, which spans the current FY partway)
Year-2 growth
6.3%
from analyst next-FY consensus
Starting EBIT margin
25.9%
from latest FY EBIT margin (GAAP)
Tax rate
15.7%
from 3-year median of EffectiveTaxRate
Starting ROIC
18.4%
NOPAT₀ ÷ invested capital, capped at 40.0%

Constants

Horizon
10 years
WACC
9.0%
Terminal growth
2.5%
Terminal ROIC
11.0%

Yearly projection

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $116.30B 20.7% $31.48B 27.1% $26.53B 17.6% $31.25B -$4.72B 0.917 -$4.33B
2 $142.18B 22.3% $40.16B 28.2% $33.85B 16.9% $43.35B -$9.49B 0.842 -$7.99B
3 $173.82B 22.3% $51.15B 29.4% $43.12B 16.2% $57.36B -$14.24B 0.772 -$11.00B
4 $207.60B 19.4% $63.55B 30.6% $53.57B 15.4% $67.77B -$14.20B 0.708 -$10.06B
5 $242.08B 16.6% $76.97B 31.8% $64.88B 14.7% $77.04B -$12.16B 0.650 -$7.90B
6 $275.46B 13.8% $90.83B 33.0% $76.57B 13.9% $83.83B -$7.27B 0.596 -$4.33B
7 $305.66B 11.0% $104.41B 34.2% $88.01B 13.2% $86.63B $1.38B 0.547 $755.1M
8 $330.56B 8.1% $116.82B 35.3% $98.47B 12.5% $83.88B $14.59B 0.502 $7.32B
9 $348.15B 5.3% $127.15B 36.5% $107.18B 11.7% $74.22B $32.96B 0.460 $15.18B
10 $356.85B 2.5% $134.55B 37.7% $113.42B 11.0% $56.69B $56.73B 0.422 $23.96B
Sum of PV of FCF (years 1-10) $1.60B

Terminal value

NOPATN+1
$116.25B
ReinvestmentN+1
$25.78B
FCFN+1
$90.48B
Terminal value (undiscounted)
$1.39T
PV of terminal value
$587.98B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $90.48B ÷ (9.0% − 2.5%).

Equity bridge

PV of operating FCF $1.60B
+ PV of terminal value $587.98B
= Enterprise value $589.58B
− Total debt $54.99B
+ Cash & equivalents $21.69B
= Equity value $556.28B
÷ Diluted shares 2.45B
= DCF PV / share $227.50
Market price $227.50
Reconciliation delta +0.0% (≈ 0 by construction)
Full calculation trail Click to expand — every number on this page derived step by step.

0 · TTM reconstruction (anchor: Q12026, 2026-03-29)

The latest filing is a 10-Q, so "base year" revenue / EBIT / OCF / CapEx are reconstructed as trailing-twelve-month values. Per-quarter facts (typical for income-statement items) get summed across four quarters; YTD-cumulative facts (typical for cash-flow items) use prior FY + YTDnow − YTDprior year same quarter.

Revenue
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-29): $24.06B
  • Q4 FY25 (2025-12-28): $24.56B
  • Q3 FY25 (2025-09-28): $23.99B
  • Q2 FY25 (2025-06-29): $23.74B
  • = $96.36B
EBIT
Sum of the four most recent per-quarter values
  • Q1 FY26 (2026-03-29): $5.99B
  • Q4 FY25 (2025-12-28): $4.97B
  • Q3 FY25 (2025-09-28): $7.49B
  • Q2 FY25 (2025-06-29): $6.49B
  • = $24.94B
OCF
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-28): +$24.53B
  • Q1 FY26 (2026-03-29) YTD: +$2.51B
  • Q1 FY25 (2025-03-30) YTD: −$4.17B
  • = $22.87B
CapEx
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-12-28): +$4.83B
  • Q1 FY26 (2026-03-29) YTD: +$1.05B
  • Q1 FY25 (2025-03-30) YTD: −$795.0M
  • = $5.09B
Prior-year TTM revenue (growth-calc baseline)
Sum of the four most recent per-quarter values
  • Q1 FY25 (2025-03-30): $21.89B
  • Q4 FY24 (2024-12-29): $22.52B
  • Q3 FY24 (2024-09-29): $22.47B
  • Q2 FY24 (2024-06-30): $22.45B
  • = $89.33B

1 · Enterprise-value target (what the DCF must match)

Market cap   = price × diluted shares
             = $227.50 × 2.45B
             = $556.28B

EV target    = market cap + total debt − cash & equivalents
             = $556.28B + $54.99B − $21.69B
             = $589.58B
            

2 · Starting NOPAT (base year 0)

GAAP EBIT          = $24.94B   (25.9% of revenue)
× (1 − tax rate)  = × (1 − 15.7%) = × 0.8429
= NOPAT₀            = $21.02B
            

3 · Invested capital & starting ROIC

Invested capital = total debt + book equity − cash
                 = $54.99B + $81.19B − $21.69B
                 = $114.48B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $21.02B / $114.48B
                 = 18.4%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · Growth path construction

Source       = analyst consensus (absolute forecast, TTM-anchored): Y1 = 4.7%, Y2 = 6.3%
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 6.3% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Plateau      = 3 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 7 years

Effective Y1 growth after solver bumps = 20.7%
Effective Y2 growth after solver bumps = 22.3%
Growth by year:
  Y1 = 20.7%
  Y2 = 22.3%
  Y3 = 22.3%
  Y4 = 19.4%
  Y5 = 16.6%
  Y6 = 13.8%
  Y7 = 11.0%
  Y8 = 8.1%
  Y9 = 5.3%
  Y10 = 2.5%
            

5 · Margin path construction

Starting margin (Y0) = 25.9%   (source: latest FY EBIT margin (GAAP))
Target margin (Y10)  = 37.7%   (solver output, normal band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 27.1%
  Y2 = 28.2%
  Y3 = 29.4%
  Y4 = 30.6%
  Y5 = 31.8%
  Y6 = 33.0%
  Y7 = 34.2%
  Y8 = 35.3%
  Y9 = 36.5%
  Y10 = 37.7%
            

6 · ROIC path construction

The capex heuristic compares latest-period CapEx ($5.09B) against the Normalized CapEx (3-yr mean) of $4.60B — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx 1.11× the 3-yr mean of $4.60B — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 18.4%; ROIC_terminal = 11.0%

ROIC by year:
  Y1 = 17.6%
  Y2 = 16.9%
  Y3 = 16.2%
  Y4 = 15.4%
  Y5 = 14.7%
  Y6 = 13.9%
  Y7 = 13.2%
  Y8 = 12.5%
  Y9 = 11.7%
  Y10 = 11.0%
            

7 · Solver iterations

Each row is one bisection attempt. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible attempt is the one the page uses. If no combination reconciles, the page shows the attempt whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 39.8% $354.45B −39.9% no
2 normal 3y +2pp 39.8% $377.93B −35.9% no
3 normal 3y +4pp 39.8% $403.49B −31.6% no
4 normal 3y +6pp 39.8% $431.30B −26.8% no
5 normal 3y +8pp 39.8% $461.51B −21.7% no
6 normal 3y +10pp 39.8% $494.31B −16.2% no
7 normal 3y +12pp 39.8% $529.91B −10.1% no
8 normal 3y +14pp 39.8% $568.49B −3.6% no
9 normal 3y +16pp 37.7% $589.58B +0.0% yes ✓

8 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $113.42B × (1 + 2.5%)
                    = $116.25B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $2.84B
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $2.84B / 11.0%
                    = $25.78B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $116.25B − $25.78B
                    = $90.48B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $90.48B / (9.0% − 2.5%)
                    = $1.39T

PV(TV)              = TV / (1 + WACC)^10
                    = $1.39T / 2.367
                    = $587.98B
            

9 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = $1.60B
+ PV(TV)          = $587.98B
= Enterprise value = $589.58B   (≈ EV target $589.58B by construction)
− Total debt      = $54.99B
+ Cash            = $21.69B
= Equity value    = $556.28B
÷ Diluted shares  = 2.45B
= DCF PV / share  = $227.50

Market price      = $227.50
Reconciliation Δ  = +0.0%   (≈ 0 by construction — the solver anchored on this price)
            
Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the company-facts methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for JNJ (CIK 0000200406); analyst growth forecasts come from analyst consensus. Share price is the latest split-adjusted close from our daily history (live quote as fallback). Per-share denominators are split-adjusted to today's share count.